According to FutureWise analysis the market for Antimicrobial Peptides in 2023 is US$ 5.62 billion, and is expected to reach US$ 8.97 billion by 2031 at a CAGR of 6.00%.
Antimicrobial peptides (AMPs) are short proteins produced by various organisms, including humans, animals, plants, and bacteria. They have broad-spectrum antimicrobial activity against bacteria, fungi, viruses, and parasites. Antimicrobial peptides (AMPs) are a fundamental element of the innate immune system, functioning as the body's initial barrier against infections. AMPs have a variety of different mechanisms of action. Some AMPs disrupt the cell membrane of microbes, leading to cell death. Other
AMPs interfere with microbial metabolism or protein synthesis. Still, others activate the host immune system to kill microbes. AMPs have several advantages over traditional antibiotics. They are effective against a wide range of microbes, including drug-resistant strains. They are also relatively non-toxic to human cells. Additionally, AMPs are less likely to induce microbial resistance than traditional antibiotics.
AMPs are still in the early stages of development as therapeutic agents. However, they have the potential to revolutionize the way that we treat infections. AMPs are being investigated for a wide range of applications, including treating drug-resistant infections, preventing infections, and treating inflammatory diseases and cancer. Some examples of AMPs and their sources are Human AMPs: LL-37, defensins, cathelicidins; Animal AMPs: Magainins (frogs), melittin (bees), statins (salivary proteins); Plant AMPs: Thionins (barley), defensins (potatoes), cecropins (moth larvae); Bacterial AMPs: Nisin (Lactococcus lactis), subtilin (Bacillus subtilis).
FutureWise Market Research has published a report that provides an insightful analysis of Antimicrobial Peptides Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Antimicrobial Peptides Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.